N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer.

N6AMT1 has shown excellent diagnostic and prognostic capabilities in a variety of cancers, and it may reshape the tumor microenvironment and contribute to the ability to predict response to immunotherapy.